NDUFB9 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

NDUFB9 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 17 amino acids near the carboxy terminus of human LYRM3.

  Source: Synthetic

  (Accession #: Q9Y6M9)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: NDUFB9
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-77138.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for NDUFB9 Antibody Blocking Peptide

• B22
• CI-B22
• complex I B22 subunit
• Complex I-B22
• FLJ22885
• LYR motif-containing protein 3
• LYRM3DKFZp566O173
• NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa
• NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9
• NADH-ubiquinone oxidoreductase B22 subunit
• UQOR22NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 (22kD, B22)

Background

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed to be not involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: NDUFB9